Stocks · News reference
McKesson Corporation has declared a quarterly dividend of $0.94 per share, payable on January 4, 2027, to shareholders of record as of December 1, 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
A research study co-authored by representatives from McKesson/The US Oncology demonstrates that ambient AI technology significantly improves documentation efficiency and reduces provider burnout in community oncology practices.
McKesson Corporation has announced a quarterly dividend payment of $0.94 per share.
Amgen and Bristol Myers Squibb represent different investment approaches in pharmaceuticals. Amgen demonstrates stronger revenue growth (~10% YoY) with higher profitability margins (21%) but trades at a premium valuation (P/E 26.4x). Bristol Myers Squibb offers significantly lower valuation (P/E 12.96x) and higher dividend yield (4.1%) with stronger free cash flow ($12.8B), though facing revenue headwinds and generic competition. For long-term dividend-focused investors, Bristol Myers Squibb is recommended despite near-term challenges.